November 2023 in “Italian journal of dermatology and venereology” This review discusses the complex factors contributing to telogen effluvium, including stress and COVID-19, and highlights current understanding and future directions for treatment, but reports no new results.
April 2024 in “Brazilian Journal of Health Review” This study aimed to evaluate the incidence of telogen effluvium in patients from Guanambi-BA who had a prior COVID-19 infection, noting a lack of extensive research on the connection between COVID-19 and the development of this hair loss condition.
This review explores the connection between COVID-19 infection and telogen effluvium, highlighting the potential contribution of inflammatory and emotional factors to hair loss; it reports no clinical results.
March 2022 in “Brazilian Journal of Health Review” This study suggests that COVID-19 infection can lead to telogen effluvium, typically occurring 3-6 months post-infection, potentially linked to the virus's inflammatory and anticoagulation effects.
August 2026 in “Derecho y cambio social.” In this study, the authors concluded that post-dengue telogen effluvium is a common but underdiagnosed condition causing temporary hair loss, primarily affecting young women, with significant emotional impacts such as anxiety and decreased self-esteem.